Absence of QTc prolongation in a thorough QT study with subcutaneous liraglutide, a once-daily human GLP-1 analog for treatment of type 2 diabetes. (Q43279508)
Jump to navigation
Jump to search
scientific article published on 8 September 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Absence of QTc prolongation in a thorough QT study with subcutaneous liraglutide, a once-daily human GLP-1 analog for treatment of type 2 diabetes. |
scientific article published on 8 September 2009 |
Statements
Absence of QTc prolongation in a thorough QT study with subcutaneous liraglutide, a once-daily human GLP-1 analog for treatment of type 2 diabetes (English)
Dhruba J Chatterjee
Milan Zdravkovic
Craig R Sprenger
Jeffrey S Litwin
8 September 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference